Breast Cancer Imaging Market Size, Share, By Technology (Ionizing Breast Imaging Techniques [Mammography, Tomography, 3D Breast Tomosynthesis], and Non-ionizing Breast Imaging Techniques [Ultrasound, MRI, Breast Microwave Imaging]), End Users (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others) and Region - Trends, Analysis, and Forecast till 2035

• By 2035, the breast cancer imaging market is expected to increase at a rate of USD 14.1 Billion.
• Breast cancer imaging market size was worth at USD 6.0 Billion, in 2024.
• The market is expanding at a 9.0% CAGR.

Breast cancer imaging is a type of medical imaging techniques that used to detect, diagnose, and monitor breast cancer. This imaging method help to identifying abnormalities in the breast tissue, by using mammography, ultrasound, MRI, and others techniques. These techniques help healthcare providers identify abnormal changes in the breast tissue, detect early signs of cancer, and assess the extent of the disease. Early detection in imaging technique plays a crucial role in improving the chances of successful treatment and outcomes.

The rising prevalence of breast cancer, rises the awareness of early detection, leads to greater demand for advanced imaging techniques to diagnose the diseases and improve treatment outcomes. Technological innovations in imaging technologies, and many government & privet organization are investing to enhance accuracy of diagnosis, resulting to drive breast cancer imaging market growth. 

Integration of artificial intelligence and machine learning in breast cancer imaging creates a major opportunity for target market. The increasing demand for personalized medicine, growing adoption of point-of-care devices, and development in liquid biopsy technologies, is estimated to growth of breast cancer imaging market share.

Impact of Generative AI on Breast Cancer Imaging Market:

• AI can be integrated with various imaging techniques, such as mammography, MRI, 3D tomosynthesis, and ultrasound to improve the accuracy, efficiency and patient outcomes, through diagnosis. AI-powered imaging tools can monitor changes in tumor size, shape, and other characteristics over time, helping doctors to assess the effectiveness of treatment. Machine learning algorithm help to recognize complex patterns in breast tissue and abnormalities more accurately.

Key Drivers of Target Market:

Rising Healthcare Investments can Stimulate Market Augmentation

Rising breast cancer incidence in both developed and developing countries leads to the cancer related deaths in women. Thus, government and healthcare organization are investing to support breast imaging research and education to encourage regular imaging screening, and boost the demand for imaging devices and services. The increasing focus on early detection and prevention leads the growing demand for regular imaging screening for women. Governments and healthcare agencies are more funding into AI research and imaging technologies, to analyze medical images more accurately and efficiently, resulting to drive breast cancer imaging market growth.

High Cost of Advanced Imaging Technologies Disrupt the Target Market Growth

Advanced breast cancer imaging technologies, such as 3D mammography, MRI, and AI-powered system, are often costly for smaller labs at initial setup. The high price of these devices can limit their adoption in low-resource, and developing countries.

• Counterbalance Statements: Technological advancement and increases in production scale can be responsible to reduce cost of these system. Government subsidies, and insurance schemes are making easier to healthcare providers to adopt advanced imaging technologies.

Opportunities & Market Trends:

Technological Advancements in Breast Imaging Market Rise the Market Growth

New technologies include several medical imaging techniques that used to visualize internal structures of the breast. These techniques are primarily used for the detection, diagnosis and screening of breast diseases, such as digital breast tomosynthesis (DBT) and contrast- enhanced digital mammography (CESM) can provide three-dimensional breast images.  MRI scans technique helps to detect tumors in women with dense breasts or breast implants. The advancement in technology for breast imaging is help for accurate and early detection of breast cancer, is anticipated to growth of breast cancer imaging market share.

• For instance, according to article published by, Brazilian Society of Mastology, this article states that, recent advances in breast radiology, particularly in the context of screening and diagnostic imaging. These advances have significantly improved the accuracy and efficiency of breast cancer detection. This article highlights new breast imaging methods, such as 3D mammography or digital breast tomosynthesis (DBT) is an emerging technology that provides a three-dimensional view of the breast, improving the detection of small or dense tumors and reducing false positives. Contrast-enhanced mammography used to enhance mammographic images, help to identify more accurate cancer tumors.

The breast cancer imaging market is segmented into technology, end-user and region.

Technology:

Based on technology, breast cancer imaging market is divided into ionizing breast imaging techniques, non-ionizing breast imaging techniques. The ionizing breast imaging techniques, hold the largest breast cancer imaging market share, as it uses radiation to capture images of the breast tissue. It contains mammography, tomosynthesis and other techniques, are commonly used in screening programs and enhance effectiveness of dense breast tissue, resulting to segment’s growth in breast cancer imaging market size.

Non-ionizing breast imaging techniques hold the second highest breast cancer imaging market share. The target market growth is driven by, increasing use of non-ionizing methods in combination with ionizing techniques, and help to improve diagnostic accuracy and monitoring.

End-user:

Hospitals, diagnostic imaging centers, are the categorized by the end-user for breast cancer imaging market. Hospitals segment dominates in target market, as it offer primary source of breast cancer screening, diagnostics and treatment.  Hospitals are equipped with advanced imaging technologies such as MRI, contrast-enhanced mammography, and it contains skilled healthcare professionals to operate these technologies, is projected to drive segment’s growth breast cancer imaging market share.

Diagnostic imaging centers are the second-dominant end-user segment in the breast cancer imaging market. These centers are equipped with specialized facilities on diagnostic procedures, and aim to give patients with extra care under specialists for imaging assessments, is projected to drive segment’s growth in target market.

• For instance, in December 2024, Martha,s Vineyard Hospital offered new breast imaging service for the breast cancer first time on the Island. The hospital purchased a breast MRI coil, which allows for the breast tissue imaging of the patients. Martha's Vineyard Hospital aimed to reduce the burden for patients and ensure that high-quality breast cancer screenings were available in Island.

Regional Insights:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This region hold the largest share of 39.9% in breast cancer imaging market, due the increasing number of breast cancer cases in this region. The rising applications in the healthcare sector, growing funding for research, well-established healthcare infrastructure and presence of major healthcare companies, is anticipated to growth of breast cancer imaging size.

• U.S. Breast Cancer Imaging Market Insights:

In the North America region, the U.S. is the dominant country in the breast cancer imaging market. The growing adoption of breast cancer imaging techniques, including 3D mammography, MRI, ultrasound, and other advanced techniques, growing government funding to accelerate research, is expected to drive target market growth.

Asia Pacific: Asia Pacific is the fastest growing region in the target market share, due to growing incidence of breast cancer in countries such as, China and India. Growing breast health awareness in peoples and technological advancements, and aging demographic drive demand for early detection and diagnosis, can drive the target market in upcoming years.

• Japan Breast Cancer Imaging Market Insights:

 The breast cancer imaging market, Japan is the dominant country in Asia Pacific region. Japan has a highly developed healthcare infrastructure, with cutting-edge medical technologies, including advanced breast cancer imaging techniques, and the presence of major medical device manufacturing companies, is anticipated to drive target market share.

Europe: Europe is another significantly growing region in target market. The advancement in healthcare system, strong government support, well-established healthcare system, and growing adoption of advanced medical imaging technologies, such as mammography, 3D mammography, and others, is anticipated to growth of target market size.

Germany Breast Cancer Imaging Market Insights:

In the Europe region for the breast cancer imaging market, Germany is considered the dominant country. The breast cancer imaging market is driven by, highly developed healthcare system, strong national breast cancer screening programs, and growing demand for early cancer detection and early diagnosis.

Breast Cancer Imaging Market Report Scope:

Segmentation:

By Technology:

• Ionizing Breast Imaging Techniques
  • Mammography
  • Tomography
  • 3D Breast Tomosynthesis
• Non-ionizing Breast Imaging Techniques
  • Ultrasound
  • MRI
  • Breast Microwave Imaging

By End-user:

• Hospitals and Clinics
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the breast cancer imaging market include GE Healthcare, Siemens Healthineers, Hologic, Inc., and others. The growing demand for advanced medical solutions, and companies are adopting strategies, such as new product launches, partnerships, agreement, higher investments and collaboration with other organization, is projected to drive breast cancer imaging market growth.

Breast Cancer Imaging Market Companies:

• GE Healthcare
• Siemens Healthineers
• Hologic, Inc.
• CANON MEDICAL SYSTEMS CORPORATION
• CMR Naviscan
• FUJIFILM India Private Limited
• Samsung Medison Co., Ltd.
• Koninklijke Philips N.V.
• AURORA HEALTHCARE US CORP
• Delphinus Medical Technologies, Inc.
• Dilon Technologies
• KUBTEC
• Planmed Oy
• Micrima
• Carestream Health

View an Additional List of Companies in the Breast Cancer Imaging Market

• In November 2024, Siemens Healthineers launched 3D mammography with artificial intelligence, known as Transpara AI, an advancement in breast cancer detection and women healthcare. The AI-powered software used machine learning algorithms to highlight areas of concern, suggest potential abnormalities, and help prioritize cases based on risk factors. It combined 3D mammography with AI, which reduces human error, increases efficiency, and leads to earlier detection of breast cancer. This integration helped healthcare professionals to make more informed decisions, and improve patient outcomes.
• In October 2024, Vera Company specialized in AI healthcare technology, raised USD 8.9 million funding in India for early breast cancer detection. This funding helps to the company for the artificial intelligence-based tools, which are designed to assist radiologists for detection of breast cancer in early stage. Vera’s AI platform aimed to reduce false positives of test, increased cancer detection rates, and enhanced workflow efficiency for radiologists.
• In September 2024, Siemens Healthcare got approval from the Food and Drug Administration’s for the tomosynthesis or three-dimensional breast imaging technology known as, Mammomat B.brilliant mammography system. This system include tomosynthesis technology, which enhances breast cancer detection with clearer images as compared to 2D mammograms. Mammomat B.Brilliant mammography system aimed to improve breast cancer imaging, by enhancing patient outcomes.
• In July 2024, LG Electronics launched B2B medical device in market with its 21HQ613D-B diagnostic monitor aimed to enhance the quality of breast cancer imaging, particularly in mammography and breast tomosynthesis. 5MP IPS diagnostics monitor, designed to offer high-definition radiological images with tailored features aimed to meet specific need of medical imaging professionals. This feature designed to improve diagnostic accuracy, increase workflow efficiency, and reduce environmental impact.
• In May 2023, KUBTEC launched MOZART iQ 3D Margin Management System, a advanced imaging technology and 3D tomosynthesis x-ray technology. This technology aimed to provide breast surgeons with clear view of surgical margins and enhance barest cancer surgery. It was aimed to provide surgeons with the ability to perform more accurate and precise surgeries, by reduced the need for repeat surgeries and improved patient outcomes.

Analyst View:

Breast cancer imaging market is driven by advancements in technology, and increasing awareness about breast cancer for early detection of cancer. The growing demand for personalized treatment medicines, and expansion of imaging techniques such as MRI, ultrasound for the accurate breast cancer detection, is anticipated to drive target market growth. The rising incidence of breast cancer among women aged 40 and over, led to the demand of effective screening and diagnostic services, resulting to growth of breast cancer imaging market share in upcoming years.

More Related Reports

Breast Imaging Market
HER2-Positive Breast Cancer Market
Breast Cancer Diagnostics Market
Breast Surgery Retractors Market
Automated Breast Ultrasound Systems (ABUS) Market